LP Peptide
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including LP Peptide rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 20 Aug 2026 | Fail | Retatrutide LP Peptide | lab name | View COA | |||
| 18 Aug 2026 | Pass | BPC-157 LP Peptide | lab name | View COA | |||
| 15 Aug 2026 | Pass | GHK-Cu LP Peptide | lab name | View COA | |||
| 13 Aug 2026 | Pass | Retatrutide LP Peptide | lab name | View COA | |||
| 3 Aug 2026 | Pass | Retatrutide LP Peptide | lab name | View COA | |||
| 3 Aug 2026 | Pass | Retatrutide LP Peptide | lab name | View COA | |||
| 30 Jul 2026 | Fail | Tesamorelin LP Peptide | lab name | View COA | |||
| 30 Jul 2026 | Fail | Tesamorelin LP Peptide | lab name | View COA | |||
| 23 Jul 2026 | Fail | GHK-Cu LP Peptide | lab name | View COA | |||
| 20 Jul 2026 | Fail | Tesamorelin LP Peptide | lab name | View COA | |||
About LP Peptide test results from Finnrick
LP Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 30 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible LP Peptide peptides in this dataset are Retatrutide (13 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 30 recent tests.